schizandrin c has been researched along with schizandrin in 26 studies
| Studies (schizandrin c) | Trials (schizandrin c) | Recent Studies (post-2010) (schizandrin c) | Studies (schizandrin) | Trials (schizandrin) | Recent Studies (post-2010) (schizandrin) |
|---|---|---|---|---|---|
| 70 | 0 | 36 | 192 | 0 | 114 |
| 70 | 0 | 36 | 20 | 0 | 9 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (15.38) | 18.7374 |
| 1990's | 2 (7.69) | 18.2507 |
| 2000's | 4 (15.38) | 29.6817 |
| 2010's | 14 (53.85) | 24.3611 |
| 2020's | 2 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Song, WZ; Tong, YY; Wang, K | 1 |
| Liu, GT | 2 |
| Lesca, P; Liu, KT | 2 |
| Che, CT; Ip, SP; Ko, KM | 1 |
| Kim, SH; Kim, SR; Kim, YC; Koo, KA; Lee, MK; Lee, NG; Markelonis, GJ; Oh, TH; Sung, SH; Yang, JH | 1 |
| Huang, M; Jin, J; Liu, GT; Sun, H | 1 |
| Chen, W; Gao, S; Sun, L; Tai, Z; Wei, H; Xu, W | 1 |
| Lin, X; Shaw, PC; Song, JX; Sze, SC; Tong, Y; Wong, RN; Zhang, YB | 1 |
| Guan, M; Li, T; Liu, Y; Sheng, Y; Wang, Y; Yuan, G | 1 |
| Cai, Q; Du, SS; Zheng, LS | 1 |
| Lin, HC; Wang, GL; Zhang, LX; Zhu, HY | 1 |
| An, LB; Cui, L; Dong, PP; Fang, ZZ; Gonzalez, FJ; Li, WT; Song, JH; Sun, XY; Wang, LX; Wu, X; Zhang, YY; Zhao, DW | 1 |
| Feng, YL; Li, W; Liu, KY; Liu, YL; Song, YG; Su, D; Yang, LJ | 1 |
| Cheng, X; Ding, XY; Ji, JD; Lu, TL; Mao, CQ; Su, LL; Wang, LJ; Zhang, J | 1 |
| Freysdottir, J; Hanski, L; Karhu, E; Kortesoja, M; Olafsdottir, ES | 1 |
| Fu, X; Li, J; Yu, Z; Zhu, P | 1 |
| Bi, K; Gao, H; Li, Q; Liu, H; Liu, R; Lv, X; Xu, H; Zhang, M; Zhang, Q; Zhang, Y | 1 |
| Bi, K; Li, Q; Li, S; Xu, H; Yang, P; Zhang, Q; Zhang, Y | 1 |
| Jing, H; Li, H; Qiu, X; Song, H; Wang, C; Xu, M; Zhao, C; Zhuang, W | 1 |
| Choi, YW; Ferreira, D; Khan, IA; Khan, SI; Srinivas, PV; Takamatsu, S; Zhao, J | 1 |
| Bae, K; Chung, HJ; Hong, JY; Hung, TM; Kang, SS; Kang, YJ; Kim, SJ; Kim, YS; Lee, SK; Min, HY; Park, EJ; Woo, ER; Youn, UJ | 1 |
| Ding, K; Gao, JM; Lei, M; Lin, ZW; Liu, HW; Padula, D; Pescitelli, G; Wang, F; Yu, XZ | 1 |
| Adámková, L; Carnecká, M; Humpa, O; Páchniková, G; Porubová Koubíková, L; Slanina, J; Slaninová, I; Smejkal, K | 1 |
| Cao, YF; Dou, TY; Feng, L; Ge, GB; Hao, DC; He, YQ; Hong, JY; Wang, P; Wu, JJ; Yang, L | 1 |
2 review(s) available for schizandrin c and schizandrin
| Article | Year |
|---|---|
[Biochemical and pharmacologic effects of wuweizi (Schizandra chinensis (Turcz.) Baill.) and its chemical contents on animal livers].
Topics: Animals; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Cyclooctanes; Cytochrome P-450 Enzyme System; Drugs, Chinese Herbal; Lignans; Liver; Mitochondria, Liver; Polycyclic Compounds | 1988 |
Schisandra fruits for the management of drug-induced liver injury in China: A review.
Topics: Alanine Transaminase; Animals; Anti-Inflammatory Agents; Antioxidants; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; China; Cyclooctanes; Drugs, Chinese Herbal; Fruit; Humans; Lignans; Liver; Liver Regeneration; Phytotherapy; Polycyclic Compounds; Schisandra | 2019 |
24 other study(ies) available for schizandrin c and schizandrin
| Article | Year |
|---|---|
[Determination of the active ingredients in Chinese drug wuweizi (Schisandra chinensis) by TLC-densitometry].
Topics: Chromatography, Thin Layer; Cyclooctanes; Densitometry; Dioxoles; Drugs, Chinese Herbal; Lignans; Polycyclic Compounds | 1990 |
Pharmacological actions and clinical use of fructus schizandrae.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cyclooctanes; Cytochrome P-450 Enzyme System; Dioxoles; Drugs, Chinese Herbal; Hepatitis B; Humans; Lignans; Lipid Peroxidation; Mice; Microsomes, Liver; Polycyclic Compounds; Rats | 1989 |
Pharmacological properties of dibenzo[a,c]cyclooctene derivatives isolated from Fructus Schizandrae chinensis. I. Interaction with rat liver cytochrome P-450 and inhibition of xenobiotic metabolism and mutagenicity.
Topics: Animals; Aryl Hydrocarbon Hydroxylases; Cyclooctanes; Cytochrome P-450 Enzyme System; Dioxoles; In Vitro Techniques; Lignans; Male; Medicine, Chinese Traditional; Medicine, East Asian Traditional; Microsomes, Liver; Mutagens; NADP; Oxidation-Reduction; Plants, Medicinal; Polycyclic Compounds; Rats; Rats, Inbred Strains | 1982 |
Pharmacological properties of Dibenzo[a,c]cyclooctene derivatives isolated from Fructus Schizandrae Chinensis III. Inhibitory effects on carbon tetrachloride-induced lipid peroxidation, metabolism and covalent binding of carbon tetrachloride to lipids.
Topics: Animals; Carbon Tetrachloride; China; Cyclooctanes; Dioxoles; Lignans; Lipid Metabolism; Lipid Peroxides; Male; Mice; Mice, Inbred DBA; Microsomes, Liver; NADP; Oxygen Consumption; Plants, Medicinal; Polycyclic Compounds | 1982 |
Structure-activity relationship of schisandrins in enhancing liver mitochondrial glutathione status in CCl4-poisoned mice.
Topics: Animals; Carbon Tetrachloride Poisoning; Chemical and Drug Induced Liver Injury; Cyclooctanes; Dioxoles; Drugs, Chinese Herbal; Female; Glutathione; Glutathione Reductase; Lignans; Mice; Mice, Inbred BALB C; Mitochondria, Liver; Polycyclic Compounds; Structure-Activity Relationship | 1998 |
Dibenzocyclooctadiene lignans from Schisandra chinensis protect primary cultures of rat cortical cells from glutamate-induced toxicity.
Topics: Animals; Calcium; Cells, Cultured; Cerebral Cortex; Cyclooctanes; Dioxoles; Dose-Response Relationship, Drug; Glutamic Acid; Intracellular Fluid; Lignans; Neurons; Neuroprotective Agents; Neurotoxins; Peroxides; Phytotherapy; Plant Extracts; Polycyclic Compounds; Rats; Schisandra | 2004 |
Reversal of P-glycoprotein-mediated multidrug resistance of cancer cells by five schizandrins isolated from the Chinese herb Fructus Schizandrae.
Topics: Animals; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line, Tumor; Cyclooctanes; Dioxoles; Doxorubicin; Drug Evaluation, Preclinical; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drugs, Chinese Herbal; Fruit; Genes, MDR; Humans; Lignans; Mice; Mice, Nude; Neoplasm Proteins; Phytotherapy; Plant Preparations; Polycyclic Compounds; Protein Kinase C; Schisandra; Xenograft Model Antitumor Assays | 2008 |
A simple and sensitive HPLC method for the simultaneous determination of eight bioactive components and fingerprint analysis of Schisandra sphenanthera.
Topics: Chromatography, High Pressure Liquid; Cyclooctanes; Dioxoles; Fruit; Lignans; Mass Spectrometry; Plant Extracts; Polycyclic Compounds; Reproducibility of Results; Schisandra | 2010 |
Protective effects of dibenzocyclooctadiene lignans from Schisandra chinensis against beta-amyloid and homocysteine neurotoxicity in PC12 cells.
Topics: Amyloid beta-Peptides; Animals; Apoptosis; bcl-2-Associated X Protein; Caspase 3; Cyclooctanes; Dioxoles; Homocysteine; Lignans; Neuroprotective Agents; PC12 Cells; Peptide Fragments; Polycyclic Compounds; Rats; Reactive Oxygen Species; Schisandra | 2011 |
Simultaneous and rapid determination of main lignans in different parts of Schisandra sphenanthera by micellar electrokinetic capillary chromatography.
Topics: Chromatography, Micellar Electrokinetic Capillary; Cyclooctanes; Dioxoles; Lignans; Polycyclic Compounds | 2011 |
[Study on chemical constituents from Schisandra chinensis stem].
Topics: Cyclooctanes; Guaiacol; Lignans; Phytochemicals; Plant Stems; Polycyclic Compounds; Schisandra; Sitosterols | 2014 |
[Chemical constituents from supercritical CO2 extraction of Schisandra chinensis].
Topics: Cyclooctanes; Lignans; Phytochemicals; Polycyclic Compounds; Schisandra; Sitosterols | 2014 |
Inhibition of UDP-Glucuronosyltransferases (UGTs) Activity by constituents of Schisandra chinensis.
Topics: Animals; Cyclooctanes; Dioxoles; Drugs, Chinese Herbal; Glucuronosyltransferase; Herb-Drug Interactions; Lignans; Plant Extracts; Polycyclic Compounds; Rats; Schisandra; Structure-Activity Relationship | 2015 |
[Rapid identification of the different constituents in Fructus Schisandrae Chinensis before and after processing by UHPLC-QTOF/MS~E combining with metabonomics].
Topics: Chromatography, High Pressure Liquid; Cyclooctanes; Dioxoles; Drugs, Chinese Herbal; Fruit; Lignans; Metabolomics; Polycyclic Compounds; Schisandra | 2016 |
[Analysis of lignans and their metabolites derived from Schisandra chinensis and vinegar Schisandra chinensis in rats’ plasma, bile, urine and faeces based on UHPLC-QTOF/MS].
Topics: Acetic Acid; Animals; Bile; Chromatography, High Pressure Liquid; Cyclooctanes; Dioxoles; Drugs, Chinese Herbal; Feces; Lignans; Liver Diseases, Alcoholic; Plasma; Polycyclic Compounds; Rats; Schisandra; Urine | 2016 |
Impact of dibenzocyclooctadiene lignans from Schisandra chinensis on the redox status and activation of human innate immune system cells.
Topics: B7-2 Antigen; Chlamydophila pneumoniae; Coculture Techniques; Cyclooctanes; Dendritic Cells; Gene Expression; Glutathione; HLA-DR Antigens; Humans; Immunologic Factors; Interleukin-10; Interleukin-12; Interleukin-6; Lignans; Lipopolysaccharides; Lymphocyte Activation; Oxidation-Reduction; Polycyclic Compounds; Primary Cell Culture; Reactive Oxygen Species; Schisandra; T-Lymphocytes; THP-1 Cells | 2019 |
An integrated strategy for ascertaining quality marker of Schisandra chinensis (Turcz.) Baill based on correlation analysis between depression-related monoaminergic metabolites and chemical components profiling.
Topics: Animals; Biomarkers; Chromatography, High Pressure Liquid; Cyclooctanes; Drugs, Chinese Herbal; Gas Chromatography-Mass Spectrometry; Lignans; Medicine, Chinese Traditional; Plants, Medicinal; Polycyclic Compounds; Quality Control; Rats; Schisandra; Tandem Mass Spectrometry | 2019 |
A multidimensional strategy for uncovering comprehensive quality markers of Schisandra chinensis (Turcz.) Baill based on pharmacodynamics and chemical properties.
Topics: Animals; Biomarkers; Cyclooctanes; Dioxoles; Drugs, Chinese Herbal; Lignans; Polycyclic Compounds; Rats; Schisandra | 2022 |
Inhibitory effects of Schisandrin C on collagen behavior in pulmonary fibrosis.
Topics: Animals; Collagen; Lignans; Mice; Polycyclic Compounds; Pulmonary Fibrosis | 2023 |
Schisandrene, a dibenzocyclooctadiene lignan from Schisandra chinensis: structure-antioxidant activity relationships of dibenzocyclooctadiene lignans.
Topics: Antioxidants; Cyclooctanes; Korea; Lignans; Molecular Structure; Plants, Medicinal; Schisandra; Structure-Activity Relationship | 2006 |
Antiproliferative effects of dibenzocyclooctadiene lignans isolated from Schisandra chinensis in human cancer cells.
Topics: Cell Line, Tumor; Cell Proliferation; Cyclooctanes; Humans; Lignans; Molecular Structure; Schisandra | 2008 |
Lignans from Schisandra sphenathera Rehd. et Wils. and semisynthetic schisantherin A analogues: absolute configuration, and their estrogenic and anti-proliferative activity.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Circular Dichroism; Crystallography, X-Ray; Dose-Response Relationship, Drug; Estrogens; Humans; Lignans; Magnetic Resonance Spectroscopy; Models, Molecular; Quantum Theory; Schisandra | 2013 |
Identification of key structural characteristics of Schisandra chinensis lignans involved in P-glycoprotein inhibition.
Topics: ATP Binding Cassette Transporter, Subfamily B; Cyclooctanes; Doxorubicin; G2 Phase Cell Cycle Checkpoints; Humans; Lignans; Molecular Structure; Polycyclic Compounds; Quantitative Structure-Activity Relationship; Russia; Schisandra; Seeds | 2014 |
A Naturally Occurring Isoform-Specific Probe for Highly Selective and Sensitive Detection of Human Cytochrome P450 3A5.
Topics: Biotransformation; Catalysis; Cell Line; Cytochrome P-450 CYP3A; Humans; Isoenzymes; Kinetics; Limit of Detection; Molecular Probes | 2017 |